AbbVie says Humira sales will balloon to $21 billion in 2020, shares rise

(Reuters) - AbbVie Inc on Friday said it expects its flagship drug Humira to bring $21 billion in sales by 2020, about $3 billion higher than its expectation two years ago.

Source: Reuters: Health - October 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news